Opportunity Information: Apply for PA 13 092
Apply for PA 13 092
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (SBIR)(R43/R44)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.351 Research Infrastructure Programs.
- This funding opportunity was created on Jan 25, 2013 and posted on Jan 25, 2013.
- Applicants must submit their applications by Jan 7, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses.
- Other Eligible Applicants include the following Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIH opportunity titled "Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (SBIR) (R43/R44)" (Funding Opportunity Number PA 13-092) is a Small Business Innovation Research (SBIR) grant program aimed at helping small companies turn new ideas into practical, commercial technologies that strengthen the nation s biomedical animal model infrastructure. It sits within the National Institutes of Health, specifically under the Office of Research Infrastructure Programs (ORIP) and its Division of Comparative Medicine (DCM). The core purpose is to support innovation that makes it easier to create, maintain, evaluate, improve, and reliably use animal models of human disease, along with the related biological materials that come from or support those models. In plain terms, NIH is looking for tools and methods that make animal models higher quality, more useful to researchers, and better matched to emerging research needs, ultimately supporting advances that improve both human and animal health.
A key theme of the announcement is the bridge between research and real world deployment. DCM already supports specialized Resources that develop, preserve, and distribute high quality animal models and biological materials to the broader biomedical community. This FOA is designed to complement and strengthen that ecosystem by encouraging small businesses to develop and commercialize technologies that those Resources and researchers can adopt. The focus is not only on scientific novelty, but also on practical utility: technologies that improve husbandry (the day to day care, breeding, housing, and welfare aspects), characterization (how well a model is measured, validated, and understood), improvement (refinements that increase relevance, reproducibility, or efficiency), and overall use of animal models and associated materials in research settings.
Because it is an SBIR opportunity using the R43/R44 mechanisms, it is structured around early stage development and the path toward commercialization. Phase I (R43) typically supports feasibility and proof of concept work, while Phase II (R44) supports more advanced development, optimization, scaling, and steps that move the product or service closer to market readiness. While the text provided does not list specific research topics, the intent is broad: proposals can cover innovative approaches that enable better model creation, better phenotyping and validation, improved breeding and colony management, new enabling technologies for preserving or distributing models and materials, or other methods that remove bottlenecks and raise standards in model based biomedical research. The emphasis on "new biomedical challenges" signals interest in solutions that help the research community keep pace with evolving scientific questions, including the need for more predictive, better characterized, and more reproducible model systems.
Administratively, this is a discretionary grant program in the Health funding activity category and is associated with CFDA 93.351 (Research Infrastructure Programs). There is no cost sharing or matching requirement stated for applicants, which is typical for SBIR awards. Eligibility is limited to small businesses, and the announcement makes clear that non U.S. (foreign) institutions cannot apply directly, and non U.S. components of U.S. organizations are also not eligible to apply. However, foreign components, as defined under the NIH Grants Policy Statement, may be allowed in some cases, which usually means certain parts of the work could be carried out abroad if well justified and permitted under NIH policy, while the applicant organization remains a U.S. small business.
In terms of timeline, the opportunity was posted and created on January 25, 2013, with an original closing date of January 7, 2016, and it was archived on February 7, 2016. That means the specific announcement as listed is no longer open for applications, but it remains useful as a reference point for the kind of animal model enabling technology development NIH has historically funded under ORIP and DCM, and similar current SBIR solicitations may exist under updated FOA numbers. For full historical details, the archived announcement is linked at http://grants.nih.gov/grants/guide/pa-files/PA-13-092.html, and the NIH Office of Extramural Research (OER) webmaster contact is provided for access or technical issues (FBOWebmaster@OD.NIH.GOV).
FAQs: NIH SBIR - Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (R43/R44), PA-13-092
What is the name of this NIH funding opportunity?
The opportunity is titled "Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (SBIR) (R43/R44)" and it is associated with Funding Opportunity Number (FON) PA-13-092.
What type of grant program is this?
This is a Small Business Innovation Research (SBIR) grant program using the NIH R43/R44 mechanisms.
Which NIH office is associated with this opportunity?
The opportunity sits within the National Institutes of Health (NIH), specifically under the Office of Research Infrastructure Programs (ORIP) and its Division of Comparative Medicine (DCM).
What is the main goal of the program?
The core purpose is to help small companies turn new ideas into practical, commercial technologies that strengthen the nation's biomedical animal model infrastructure. The focus is on technologies that make it easier to create, maintain, evaluate, improve, and reliably use animal models of human disease, as well as related biological materials.
What kinds of projects does NIH appear to be looking for?
Based on the description provided, NIH is interested in innovations that improve animal models and their use in research settings, including technologies related to husbandry (care, breeding, housing, welfare), characterization (measurement, validation, and understanding of models), improvement (refinements that increase relevance, reproducibility, or efficiency), and broader enablement of model creation and use.
Does this opportunity emphasize commercialization?
Yes. A key theme is bridging research and real-world deployment. The FOA is designed to encourage small businesses to develop and commercialize technologies that can be adopted by DCM-supported Resources and biomedical researchers.
How does this program relate to ORIP/DCM-supported Resources?
DCM supports specialized Resources that develop, preserve, and distribute high-quality animal models and biological materials. This SBIR opportunity is intended to complement and strengthen that ecosystem by supporting small-business development and commercialization of technologies that those Resources and researchers can adopt.
What do "R43" and "R44" mean in this announcement?
They refer to SBIR award phases. Phase I (R43) typically supports feasibility and proof-of-concept work. Phase II (R44) typically supports more advanced development, optimization, scaling, and steps that move a product or service closer to market readiness.
Are specific research topics listed?
The information provided does not list specific research topics. Instead, it describes a broad intent, including model creation, phenotyping and validation, breeding and colony management, preservation and distribution technologies, and other approaches that remove bottlenecks and raise standards in model-based biomedical research.
What does "new biomedical challenges" imply here?
It signals interest in solutions that help the research community keep pace with evolving scientific questions, including the need for more predictive, better characterized, and more reproducible animal model systems.
What is the funding activity category and CFDA association?
Administratively, this is a discretionary grant program in the Health funding activity category and is associated with CFDA 93.351 (Research Infrastructure Programs).
Is cost sharing or matching required?
No cost sharing or matching requirement is stated in the information provided, which is typical for SBIR awards.
Who is eligible to apply?
Eligibility is limited to small businesses.
Can a non-U.S. (foreign) institution apply directly?
No. The announcement indicates that non-U.S. (foreign) institutions cannot apply directly.
Are non-U.S. components of U.S. organizations eligible to apply?
No. The information provided states that non-U.S. components of U.S. organizations are not eligible to apply.
Are foreign components allowed in any way?
Potentially. The information provided notes that foreign components, as defined under the NIH Grants Policy Statement, may be allowed in some cases. This generally means parts of the work could be carried out abroad if well-justified and permitted under NIH policy, while the applicant organization remains a U.S. small business.
Is this opportunity currently open?
No. The opportunity was archived on February 7, 2016, and the original closing date was January 7, 2016. That means this specific FOA is no longer open for applications.
When was this opportunity originally posted?
It was posted and created on January 25, 2013.
Why might this archived FOA still be useful?
Even though it is closed, it can serve as a reference point for the kinds of animal-model enabling technology development NIH has historically funded under ORIP and DCM. Similar current SBIR solicitations may exist under updated FOA numbers.
Where can I find the archived announcement?
The archived announcement is linked at: http://grants.nih.gov/grants/guide/pa-files/PA-13-092.html
Who is the listed contact for access or technical issues related to the announcement?
The NIH Office of Extramural Research (OER) webmaster contact provided is FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Health
Next opportunity: Office of Elementary and Secondary Education (OESEO) Office of Indian Education (OIE) Professional Development Program CFDA NUmber 84.299B
Previous opportunity: Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (STTR)(R41/R42)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 13 092
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 13 092) also looked into and applied for these:
| Funding Opportunity |
|---|
| Clinical and Public Health Curriculum Development, Training and Information Systems Support for the Haiti Health Care System under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1331 Funding Number: CDC RFA GH13 1331 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Accelerating Delivery of Comprehensive HIV/AIDS in High Prevalence, Underserved Districts In The Republic Of Uganda Under The Presidents Emergency Plan For AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1332 Funding Number: CDC RFA GH13 1332 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,203,759 |
| Capacity Strengthening to Support Provision of High Quality and Evidence based HIV Prevention, Care and Treatment Services to Staff and Family Members of the Kenya Prisons Services Staff, Family Members, and Prisoners in Kenya and Program Transition Apply for CDC RFA GH13 1308 Funding Number: CDC RFA GH13 1308 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Increasing HIV/AIDS Program Capacity through Human Resources Capacity Building to Support the Transition of the Kenya HIV Program to Local Organizations under the Presidents Emergency Plan for AIDS Relief (PEPFAR). Apply for CDC RFA GH13 1309 Funding Number: CDC RFA GH13 1309 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Technical Assistance for the Transition of Comprehensive HIV/AIDS Programs and Medical Education to Ethiopia under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA GH13 1310 Funding Number: CDC RFA GH13 1310 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $8,000,000 |
| Improving Public Health Practices and Service Delivery in the Federal Democratic Republic of Ethiopia with a Focus on HIV, Sexually Transmitted Infections, and Tuberculosis under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA GH13 1314 Funding Number: CDC RFA GH13 1314 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Strengthening Strategic Information Activities in the Kingdom of Lesotho under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA GH13 1315 Funding Number: CDC RFA GH13 1315 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,200,000 |
| Improving Implementation of Programs for Care Apply for CDC RFA GH13 1317 Funding Number: CDC RFA GH13 1317 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Technical assistance to accelerate the elimination of mother to child transmission (EMTCT) of HIV and improve HIV free child survival in the Republic of Zambia under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA GH13 1350 Funding Number: CDC RFA GH13 1350 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $10,000,000 |
| Strengthening Local Ownership for the Sustainable Provision of Comprehensive HIV/AIDS Services by the Health Bureaus of Amhara and Tigray Regional States of the Federal Democratic Republic of Ethiopia under the Presidents Emergency Plan for AIDS Reli Apply for CDC RFA GH13 1311 Funding Number: CDC RFA GH13 1311 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Strengthening Capacity for Laboratory Systems, Strategic Information, and Technical Leadership in Public Health for the National HIV/AIDS Response in the Federal Democratic Republic of Ethiopia under the Presidents Emergency Plan for AIDS Relief (PEP Apply for CDC RFA GH13 1313 Funding Number: CDC RFA GH13 1313 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Implementation of Integrated HIV/AIDS Treatment, Care and Prevention Programs in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief Apply for CDC RGA GH13 1316 Funding Number: CDC RGA GH13 1316 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Clinical Sites for an Undiagnosed Diseases Network (UDN) (U01) Apply for RFA RM 13 004 Funding Number: RFA RM 13 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Implementation of Integrated HIV/AIDS Treatment, Care and Prevention Programs in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA GH13 1316 Funding Number: CDC RFA GH13 1316 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Strengthening Community Care and Support Systems and Services (SCCSSS) in Namibia Apply for SOL 673 13 000002 Funding Number: SOL 673 13 000002 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $9,000,000 |
| Indigenous Child Health Strong Communities, Healthy Children Apply for HHS 2013 IHS HPDP 0001 Funding Number: HHS 2013 IHS HPDP 0001 Agency: Indian Health Service Category: Health Funding Amount: $100,000 |
| Providing Information System Support for Training and Implementation of National HIV Monitoring Systems in the United Republic of Tanzania under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA GH13 1318 Funding Number: CDC RFA GH13 1318 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $320,000 |
| NIA Limited Competition Renewals of, and Revisions to, Existing Cooperative agreement Awards (U01) Apply for PAR 13 097 Funding Number: PAR 13 097 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Behavioral and Serological Survey (BSS) for HIV and Syphilis among Diamond Mine Workers in Angola Apply for CDC RFA GH13 1354 Funding Number: CDC RFA GH13 1354 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Technical Collaboration with the Peoples Republic of China (PRC) on Innovative Approaches to Increase the Effectiveness of the HIV/AIDS Response in China and Globally under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1364 Funding Number: CDC RFA GH13 1364 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 13 092", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.